Ros Matthew 4
4 · Cogent Biosciences, Inc. · Filed Jun 8, 2023
Insider Transaction Report
Form 4
Ros Matthew
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-07+36,700→ 36,700 totalExercise: $11.70Exp: 2033-06-07→ Common Stock (36,700 underlying)
Footnotes (1)
- [F1]This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders.